Omzet 2024 * | 46,3 mld. 50,21 mld. | Omzet 2025 * | 49,84 mld. 54,06 mld. | Marktkapitalisatie | 112 mld. 121 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 7,08 mld. 7,68 mld. | Nettowinst (verlies) 2025 * | 8,7 mld. 9,44 mld. | EV/omzet 2024 * | 2,56 x |
Nettoschuld 2024 * | 6,68 mld. 7,25 mld. | Nettoschuld 2025 * | 2,28 mld. 2,47 mld. | EV/omzet 2025 * | 2,29 x |
K/w-verhouding 2024 * |
16
x | K/w-verhouding 2025 * |
12,9
x | Werknemers | - |
Dividendrendement 2024 * |
4,32% | Dividendrendement 2025 * |
4,55% | Vrij verhandelbaar | 87,13% |
Recentste transcriptie over Sanofi SA
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paul Hudson
CEO | Chief Executive Officer | 56 | 01-09-19 |
Madeleine Roach
COO | Chief Operating Officer | 40 | 01-01-22 |
Chief Tech/Sci/R&D Officer | 51 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Patrick Kron
BRD | Director/Board Member | 70 | 01-05-14 |
Lise Kingo
BRD | Director/Board Member | 62 | 28-04-20 |
Gilles Schnepp
BRD | Director/Board Member | 64 | 22-05-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,51% | 727 mld. | |
+33,05% | 599 mld. | |
-6,23% | 354 mld. | |
+18,78% | 328 mld. | |
+1,35% | 277 mld. | |
+16,00% | 243 mld. | |
+8,09% | 205 mld. | |
-5,77% | 203 mld. | |
+6,19% | 164 mld. |